Description générale
Clindamycin is a lincosamide antibiotic with activity against gram-positive cocci and many anaerobes.
INN
Clindamycin
Codes ATC
Type de médicament
Chemical agent
Groupes d'antibiotiques
Historique des statuts LME
Ajouté pour la première fois en 1991
(TRS
825)
pour
Bacterial infection of unspecified site
Ajouté en 2017
(TRS
1006)
pour
Osteomyelitis or osteitis
Ajouté en 2017
(TRS
1006)
pour
Bacterial infection of joint
Retiré en 2017
(TRS
1006)
pour
Bacterial infection of unspecified site
Ajouté en 2021
(TRS
1035)
pour
Necrotising fasciitis
Wikipédia
DrugBank
Recommandations
Section
Access group antibiotics
- Parenteral > General injections > IV: 150 mg per mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate)
- Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride)
- Oral > Solid: 150 mg (as hydrochloride)
- Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
- Oral > Solid: 150 mg (as hydrochloride) capsule
- Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection
Indications
Premier choix
co-prescrite avec piperacillin + tazobactam Necrotising fasciitis
Autres indications